EntryPoint Capital’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162K | Buy |
+47,746
| New | +$162K | 0.08% | 523 |
|
|
2024
Q4 | – | Sell |
-51,030
| Closed | -$283K | – | 773 |
|
|
2024
Q3 | $283K | Buy |
+51,030
| New | +$283K | 0.16% | 274 |
|
|
2024
Q1 | – | Sell |
-9,567
| Closed | -$87.3K | – | 1485 |
|
|
2023
Q4 | $87.3K | Buy |
+9,567
| New | +$87.3K | 0.08% | 446 |
|